Trials / Completed
CompletedNCT04982822
Novel Senhance Robotic System in Urologic Surgery: Its Clinical Application and Implication
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 314 (actual)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
An observational study to collect data from the participants who received urologic surgeries using the Senhance Robotic system.
Detailed description
This is an observational study and investigators will collect peri-operative demographic data, and short-term outcomes (3-6 months) from the participants who received minimal invasive surgeries using Senhance robotic system in the National Taiwan University Hospital Yunlin Branch, Urology Department. The investigators want to demonstrate if the robotic system is safe and feasible in urologic laparoscopic surgeries. The operation included TEP, radical prostatectomy, radical nephrectomy (nephroureterectomy) , adrenalectomy, radical cystectomy, and ureter surgery et al. up to 2022/12, we had recruited 127 TEP, 83 radical prostatectomies, 17 adrenalectomies, 40 nephrectomies, 29 partial nephrectomies, 13 radical cystectomies and 18 other surgeries, such as ureter surgery
Conditions
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2022-12-31
- Completion
- 2024-01-31
- First posted
- 2021-07-29
- Last updated
- 2024-06-25
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04982822. Inclusion in this directory is not an endorsement.